Strides Pharma Science is currently trading at Rs. 345.30, up by 3.20 points or 0.94% from its previous closing of Rs. 342.10 on the BSE.
The scrip opened at Rs. 344.05 and has touched a high and low of Rs. 346.40 and Rs. 337.85 respectively. So far 36957 shares were traded on the counter.
The BSE group 'A' stock of face value Rs. 10 has touched a 52 week high of Rs. 550.40 on 22-Jan-2019 and a 52 week low of Rs. 337.85 on 24-Jul-2019.
Last one week high and low of the scrip stood at Rs. 369.65 and Rs. 337.85 respectively. The current market cap of the company is Rs. 3090.80 crore.
The promoters holding in the company stood at 31.24%, while Institutions and Non-Institutions held 49.51% and 19.25% respectively.
Strides Pharma Science has received the Establishment Inspection Report (EIR) from the US Food and Drug Administration (USFDA) for its formulations facility (KRSG Gardens) in Bangalore, thereby confirming the successful closure of the inspections. The facility was inspected by the USFDA in May 2019.
Strides Pharma Science (Formerly Strides Shasun) is a pharmaceutical company with a major focus on development and manufacture of IP-led niche finished dosage formulations. It is also among the world’s largest manufacturers of soft gelatin capsules.
